期刊文献+

TRAF6在NF-κB信号通路中的修饰与降解 被引量:6

Modification and Degradation of TRAF6 in the Activation of NF-κB Pathway
下载PDF
导出
摘要 目的:研究肿瘤坏死因子受体相关因子6(TRAF6)在调节NF-κB通路中的作用机制。方法:利用转导了并稳定表达TRAF6基因的293RZC细胞株,用荧光素酶报告基因系统测定CoA1对293RZC细胞NF-κB通路的激活,WesternBlot分析在NF-κB通路激活过程中TRAF6和IκBα的降解。结果:CoA1可诱导293RZC细胞NF-κB通路的激活,在这一过程中,TRAF6被修饰并降解,IκBα也发生降解,二者的降解被蛋白酶抑制剂MG132抑制。结论:TRAF6介导NF-κB通路的激活需要蛋白酶复合体的作用。 Objective:To investigate the possible roles of TRAF6 on the ac tiva tion of NF-êB pathway. Methods:293 RZC stable cell line made by transfection w ith expressible TRAF6 gene, and luciferase reporter were applied for detecting t he activation of NF-êB pathway triggered by CoA1. The modification and degrada tion of TRAF6 as well as degradation of IêBáwere determined by Western Blot as say. Results:CoA1 was able to induce activation of NF-êB pathway in the 293RZ C cells. During the course of activation, TRAF6 was modified and degraded appare ntly. Furthermore, IêBádegradation was detected simultaneously. Proteasome inh ibitor MG132 inhibited the degradation both of TRAF6 and IêBá. Conclusion:Pro teasome might be involved in activation of NF-êB pathway mediated by TRAF6.
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2004年第1期59-62,共4页 Journal of Nanjing Medical University(Natural Sciences)
关键词 肿瘤坏死因子受体相关因子6 NF-κB转录因子 蛋白酶依赖的降解 TNFR-associated factor 6(TRAF6) NF-êB proteasome-dependent degradation
  • 相关文献

参考文献7

  • 1Cao Z, Xiong J, Takeuchi M, et al. TRAF6 is a signal transducer for interleukin-1 [J]. Nature, 1996, 383:443 -446.
  • 2Ishida TK, Tojo T, Aoki T, et 02. TRAF5, a novel tumor necrosis factor receptor-associated factor family protein,mediates CD40 signaling[J] . Proe Natl Aead Sci USA,1996, 93 (18):9437-9442.
  • 3Rothe M, Sarma V, Dixit VM, et al. TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40[J].Science, 1995, 269:1424 - 1427.
  • 4Wang C, Deng L, Hong M, et al. TAKlis a tibiqui-tindependent kinase of MKK and IKK[J]. Nature, 2001,412:346 - 351.
  • 5Naito A, Yoshida H, Nishioka E, et al. TRAF6-deficient mice display hypohidrotic ectodermal dysplasia[J] . Proc Nad Acad Sci USA, 2002, 99(13): 8766-8771.
  • 6Lomaga MA, Yeh WC, Sarosi I, et al. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40,and LPS signaling[J]. Genes Dev, 1999, 13:1015 - 1024.
  • 7Scherer DC, Brockman JA, Chen Z, et al. Signal-induced degradation of IKBα requires site-specific ubiquitination.Proc Natl Acad Sci[J], 1995, 92:11259 -11263.

同被引文献59

  • 1肖振球,何译生,吕小平,梁少华,黄小薇,尹雪曼,韦永兴,高超义.自拟安肠汤治疗溃疡性结肠炎50例[J].广西中医药,1993,16(3):3-6. 被引量:20
  • 2曾广仙,刘俊英,熊金蓉,廖奕华,代丽红,李杏娟,沈关心.黄芪多糖调节创伤应激小鼠免疫功能的研究[J].中华微生物学和免疫学杂志,2004,24(12):942-945. 被引量:19
  • 3李霞,肖明振,余擎,赵守亮,郭婷,高杰,吕昕,何文喜.肿瘤坏死因子受体相关分子6在成牙本质细胞中表达的研究[J].临床口腔医学杂志,2005,21(3):143-145. 被引量:4
  • 4Mountzios G, Dimopoulos MA, Bamias A, et al. Abnormal bone remodeling process is due to an imbalance in the receptor activator of nuclear factor-kappaB ligand (RAN- KL)/osteoprotegerin (OPG) axis in patients with solid tumors metastatic to the skeleton [J]. Acta Oncol,2007,46(2):221-229.
  • 5Mizutani Y, Matsubara H, Yamamoto K, et al. Prognostic significance of serum osteoprotegerin levels in patients with bladder carcinoma[J]. Cancer,2004,101 (8) : 1794- 1802.
  • 6Ito R, Nakayama H, Yoshida K, et al. Expression of osteoprotegerin correlates with aggressiveness and poor prognosis of gastric carcinoma [J]. Virchows Arch,2003,443 (2) : 146-151.
  • 7Chen G, Sircar K, Aprikian A, et al. Expression of RANKL/RANK/OPG in primary and metastatic human prostate cancer as markers of disease stage and functional regulation[J]. Cancer,2006,107(2) :289-298.
  • 8Naugler WE, Karin M. NF-kappaB and cancer-identifying targets and mechanisms [J]. Curr Opin Genet Dev, 2008,18( 1 ) : 19-26.
  • 9Morinaga T,Nakagawa N,Yasuda H,et al. Cloning and characterization of the gene encoding human osteoprotegerin/osteoclastogenesis-inhibitory factor [J]. Eur J Biochem, 1998,254(3) :685-691.
  • 10Pahl HL. Activators and target genes of Rel/NF-kappaB transcription factors [J]. Oncogene, 1999, 18 (49) :6853- 6866.

引证文献6

二级引证文献67

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部